GARP:BATS-iShares MSCI USA Quality GARP ETF (USD)

ETF | Others |

Last Closing

USD 51.66

Change

-0.95 (-1.81)%

Market Cap

USD 0.35B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

-1.94 (-2.63%)

USD 16.66B
PAVE Global X U.S. Infrastructure D..

-0.24 (-0.62%)

USD 8.48B
INDA iShares MSCI India ETF

+0.44 (+0.89%)

USD 8.43B
BUFR First Trust Cboe Vest Fund of ..

-0.24 (-0.80%)

USD 6.47B
BOXX Alpha Architect 1-3 Month Box ..

+0.02 (+0.02%)

USD 5.42B
BBUS JPMorgan BetaBuilders U.S. Equ..

-1.12 (-1.09%)

USD 4.48B
ARKB ARK 21Shares Bitcoin ETF

-2.23 (-2.64%)

USD 3.92B
KNG FT Cboe Vest S&P 500® Dividen..

-0.25 (-0.49%)

USD 3.65B
IFRA iShares U.S. Infrastructure ET..

-0.52 (-1.13%)

USD 3.27B
GSUS Goldman Sachs MarketBeta US Eq..

-0.92 (-1.18%)

USD 2.65B

ETFs Containing GARP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.16% 9% A- 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.16% 9% A- 8% B-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.35B 88% B+ 81% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike